Conversations That Matter
No deviation’s Takeaways from ISPE France Conference – Outsourcing and Supplier Management in the Pharmaceutical Industry
Speaker: Pierre-Jean Sauzet (Procurement) and Isabelle Finet-Bouillou (Facility Management) – Sanofi.
What Sanofi’s IWX Project Reveals About the Future of Facility Management
At ISPE France 2025, the spotlight was on transformation—not the flashy kind, but the kind that quietly reshapes how pharma operates every day. One of the most compelling sessions came from Sanofi, where Pierre-Jean Sauzet (Procurement) and Isabelle Finet-Bouillou (Facility Management) unveiled Project IWX—a bold initiative to fully outsource and harmonize Facility Management (FM) across Sanofi’s global network.
Julie Loison from No deviation was in the room. Here’s what we took away:
- From Complexity to Clarity
Before 2017, each Sanofi site had its own mix of FM suppliers, leading to tangled contracts and fractured performance. The IWX project took a different path: a global partnership with CBRE covering both “soft” and “hard” services—from canteens to clean steam systems.“Nobody uses only one supplier,” said Pierre-Jean Sauzet. “But we’re aiming for as close as possible.”Why it matters: In pharma, fragmentation isn’t just inefficient—it’s a risk. This move marks a step toward controlled, scalable FM operations aligned with GxP expectations. - Soft Meets Hard (For Real This Time)
The project goes beyond better hospitality. It deliberately includes critical HVAC and utility systems essential for biologics and vaccine production.Why it matters: When FM is treated as strategic infrastructure—not just a cost center—quality and compliance improve alongside efficiency. - Rethinking Partnership
Sanofi’s leadership was clear: CBRE is not a subcontractor—it’s a partner. This shift in mindset is key to building shared goals, shared risk, and shared governance.Why it matters: For pharma companies facing talent shortages and regulatory pressure, partnerships must be built on transparency, trust, and measurable value—not just transactions. - A New Internal Operating Model
To make the external partnership work, Sanofi restructured internally. FM is now a global, centralized function, with dedicated roles for regional coordination and knowledge sharing.Why it matters: Outsourcing only works if you’re ready internally. The real value of IWX lies not just in the contract—but in how Sanofi reorganized to make it work. - Speed as a Strategy
With their Sodexo contract ending in December 2024, Sanofi worked backwards—defining a strict roadmap, appointing executive sponsors, and preparing site-by-site solutions ahead of go-live.“It’s now, not tomorrow.” That was the team’s motto.Why it matters: In pharma, where decision cycles can be slow, driving a project like IWX with urgency is a leadership act in itself.
Final Thought
Project IWX is more than a procurement story. It’s a glimpse into how pharma giants are integrating FM into broader transformation agendas—from operational excellence to sustainability, from digitalization to employee experience.
At No deviation, we’ve long said that technical functions like CQV or FM aren’t side tasks—they’re strategic levers. Sanofi just proved the point.
Want to go deeper?
Contact us at hello@nodeviation.com and let’s have a conversation that matters.
